Virtual Medicinal Product (VMP) - Fosamprenavir 50mg/ml oral suspension
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Fosamprenavir 50mg/ml oral suspension | Start Date 23-11-2004 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- J05AE07
| BNF | Start Date | End Date |
|---|---|---|
| Current BNF 05030100 | Start Date 04-04-2022 | End Date |
| Previous BNF 05030100 | Start Date 07-04-2005 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 41763911000001106 | 09-05-2023 | |
| 416206000 | 22-10-2007 | 08-05-2023 |
| 8669911000001106 | 23-11-2004 | 21-10-2007 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Fosamprenavir calcium | Based on Base Substance | Fosamprenavir | 50 mg | 1 ml |
Name
Fosamprenavir calcium
Basis of strength description
Based on Base Substance
BOSS
Fosamprenavir
Strength and UOM (Nmr)
50.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMFosamprenavir
-
VMP(Current) Fosamprenavir 50mg/ml oral suspension
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 225 ml |